Evidence map›Paper›PMID 16077111›Full record

ArticleJournal of bacteriology2005

Shigella dysenteriae ShuS promotes utilization of heme as an iron source and protects against heme toxicity.

Elizabeth E Wyckoff, Gregory F Lopreato, Kimberly A Tipton, Shelley M Payne

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Heme Synthesis and Acquisition in Bacterial Pathogens.Journal of molecular biology · 2016
    Review
  12. The crimson conundrum: heme toxicity and tolerance in GAS.Frontiers in cellular and infection microbiology · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Role and regulation of heme iron acquisition in gram-negative pathogens.Frontiers in cellular and infection microbiology · 2013
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elizabeth E WyckoffThe University of Texas, Section of Molecular Genetics and Microbiology, 1 University Station A5000, Austin, TX 78712-0162, USA. ewyckoff@mail.utexas.edu
Gregory F Lopreato
Kimberly A Tipton
Shelley M Payne
The University of Texas at Austin · US

Funding

ROLE OF CARBON METABOLISM AND VIRULENCE OF SHIGELLA FLEXNERIR37AI016935 · NIAID · UNIVERSITY OF TEXAS AUSTIN · PI Shelley M. Payne · 2003 to 2026
$6.0M
Role of carbon metabolism in virulence of Shigella flexneriR01AI016935 · NIAID · UNIVERSITY OF TEXAS AUSTIN · PI PAYNE, SHELLEY M. · 1985 to 2017
$2.6M
NIAID NIH HHS AI16935NIAID NIH HHS R01 AI016935NIAID NIH HHS R37 AI016935
6 · The paper itself

Abstract

Shigella dysenteriae serotype 1, a major cause of bacillary dysentery in humans, can use heme as a source of iron. Genes for the transport of heme into the bacterial cell have been identified, but little is known about proteins that control the fate of the heme molecule after it has entered the cell. The shuS gene is located within the heme transport locus, downstream of the heme receptor gene shuA. ShuS is a heme binding protein, but its role in heme utilization is poorly understood. In this work, we report the construction of a chromosomal shuS mutant. The shuS mutant was defective in utilizing heme as an iron source. At low heme concentrations, the shuS mutant grew slowly and its growth was stimulated by either increasing the heme concentration or by providing extra copies of the heme receptor shuA on a plasmid. At intermediate heme concentrations, the growth of the shuS mutant was moderately impaired, and at high heme concentrations, shuS was required for growth on heme. The shuS mutant did not show increased sensitivity to hydrogen peroxide, even at high heme concentrations. ShuS was also required for optimal utilization of heme under microaerobic and anaerobic conditions. These data are consistent with the model in which ShuS binds heme in a soluble, nontoxic form and potentially transfers the heme from the transport proteins in the membrane to either heme-containing or heme-degrading proteins. ShuS did not appear to store heme for future use.

Indexed as

AerobiosisAnaerobiosisBacterial ProteinsHemeHydrogen PeroxideIronOxidantsOxidative StressPlasmidsShigella dysenteriaeBacterial ProteinsHemeHydrogen PeroxideIronOxidants

Identifiers

PMID16077111
PMCPMC1196095
OpenAlexW2104893055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.